In response to concerns about the possible adverse health effects caused by formaldehyde emission from wood-based products, the wood panel products industry has developed and produced lower emission materials over the past 15 years. There is a need for a reliable and inexpensive method in the industry to measure formaldehyde emission from these products that can be used on a routine basis and can provide data comparable to the environmental chamber test prescribed in the European pre-standard ENV 717-1. A 2.4-litre microchamber test has been developed in the UK, at the Building Research Establishment, as a bench-top method for measuring formaldehyde emission from wood-based materials. Microchamber tests of newly manufactured boards that were preconditioned for 28 days showed good correlation with the steady-state values obtained from the 1-m3 chamber tests determined in accordance with the ENV 717-1 standard. The airflow rate, the ratio of air change to material loading in the chamber and the amount of exposed edges were shown to affect the measurement of emission rates.

Keywords:
Microchamber test, Formaldehyde emission, Wood-based panel products, European standardisation
This content is only available via PDF.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.